Seyed-Ali Mostafavi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Seyed-Ali Mostafavi has a total of 283 co-authors. Here are the top co-authors by number of shared publications:
Mohammad Reza Mohammadi
Psychiatry and Psychology Research Center, Roozbeh Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
23 shared publications- Seyed Ali Keshavarz
Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
9 shared publications - Ali Khaleghi
Psychiatry and Psychology Research Center, Tehran University of Medical Sciences, Tehran, Iran
8 shared publications Mohammad Reza Eshraghian
Department of Biostatistics and Epidemiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
8 shared publications- Mohammad Reza Mohammadi
Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
8 shared publications Shahin Akhondzadeh
Psychiatry & Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
8 shared publications
Latest Publications
- Open Access
- 31 December 2025
- Published by Brieflands in Asian Journal of Sports Medicine
- Vol. 16 (4) , e169563
The Inflammatory Indicator IL-6 and BDNF Levels in Male Fitness Athletes and Their Relationship with Acute Stress Disorder: A Case-Control Study
Background: The responses of the inflammatory marker interleukin 6 (IL-6) and brain-derived neurotrophic factor (BDNF) to acute stress in fitness athletes are unknown. Objectives: This study aimed to investigate IL-6 and BDNF levels in male fitness athletes and their association with acute stress disorder using a case-control design. Methods: Ninety male fitness athletes were divided into a case group (individuals with acute stress disorder) and a control group (individuals without acute stress disorder) using a psychological diagnostic interview based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria, conducted by a clinical psychologist to reduce selection bias. Serum IL-6 and BDNF samples were collected at two time points, before and after muscular training. Data were analyzed using t tests and binary logistic regression. Results: After controlling for anxiety and depression, the association between IL-6 and acute stress disorder before muscular training was positive and significant (OR = 1.013; 95% CI, 1.003 to 1.022; P = 0.007). After muscular training, this association became negative and significant relative to the control group (OR = 0.975; 95% CI, 0.961 to 0.990; P = 0.001). Notably, after muscular training, there was a very strong positive association between BDNF and acute stress disorder (OR = 10.328; 95% CI, 1.585 to 67.318; p = 0.015). Muscular exercise increased serum IL-6 levels in the nonstressed group (mean change, 26.49 ± 39.18; P ≤ 0.001) but decreased IL-6 levels in the acute stress disorder group, which already had high serum levels (mean change, -56.87 ± 46.83; P ≤ 0.001). Conclusions: Muscular exercise increased BDNF levels in both groups. Acute stress disorder was significantly associated with increased IL-6 and BDNF levels in male fitness athletes. After physical exercise, IL-6 levels decreased, whereas BDNF levels increased. These findings are limited to male athletes.
- 31 December 2025
- Published by Brieflands in Asian Journal of Sports Medicine
- Vol. 16 (4) , e169563
Open AccessThe Inflammatory Indicator IL-6 and BDNF Levels in Male Fitness Athletes and Their Relationship with Acute Stress Disorder: A Case-Control Study
Background: The responses of the inflammatory marker interleukin 6 (IL-6) and brain-derived neurotrophic factor (BDNF) to acute stress in fitness athletes are unknown. Objectives: This study aimed to investigate IL-6 and BDNF levels in male fitness athletes and their association with acute stress disorder using a case-control design. Methods: Ninety male fitness athletes were divided into a case group (individuals with acute stress disorder) and a control group (individuals without acute stress disorder) using a psychological diagnostic interview based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria, conducted by a clinical psychologist to reduce selection bias. Serum IL-6 and BDNF samples were collected at two time points, before and after muscular training. Data were analyzed using t tests and binary logistic regression. Results: After controlling for anxiety and depression, the association between IL-6 and acute stress disorder before muscular training was positive and significant (OR = 1.013; 95% CI, 1.003 to 1.022; P = 0.007). After muscular training, this association became negative and significant relative to the control group (OR = 0.975; 95% CI, 0.961 to 0.990; P = 0.001). Notably, after muscular training, there was a very strong positive association between BDNF and acute stress disorder (OR = 10.328; 95% CI, 1.585 to 67.318; p = 0.015). Muscular exercise increased serum IL-6 levels in the nonstressed group (mean change, 26.49 ± 39.18; P ≤ 0.001) but decreased IL-6 levels in the acute stress disorder group, which already had high serum levels (mean change, -56.87 ± 46.83; P ≤ 0.001). Conclusions: Muscular exercise increased BDNF levels in both groups. Acute stress disorder was significantly associated with increased IL-6 and BDNF levels in male fitness athletes. After physical exercise, IL-6 levels decreased, whereas BDNF levels increased. These findings are limited to male athletes.
- Open Access
- 29 December 2024
- Published by Knowledge E DMCC in Iranian Journal of Psychiatry
- Vol. 20 (1) , 1-2
Potential Antidepressant Effects of Omeprazole Introduced through Network Analysis and Systems Biology Should Be Interpreted with Caution in the Clinical Environment
The Article Abstract is not available.
- 29 December 2024
- Published by Knowledge E DMCC in Iranian Journal of Psychiatry
- Vol. 20 (1) , 1-2
Open AccessPotential Antidepressant Effects of Omeprazole Introduced through Network Analysis and Systems Biology Should Be Interpreted with Caution in the Clinical Environment
The Article Abstract is not available.
- Open Access
- 11 March 2024
- Published by Knowledge E DMCC in Iranian Journal of Psychiatry
- Vol. 19 (2) , 158-173
The Effectiveness of Transcranial Direct Current Stimulation (tDCS) and Omega-3 on Food Craving, Executive Functions, Weight, and Depressive Symptoms in Patients with Depression and Overweight: A Randomized Controlled Trial
Objective: The most important hypothesis of this research was based on the fact that the mechanism of the effect of omega-3 on depression and obesity is formed through its accumulation in the dorsolateral prefrontal cortex (DLPFC), especially in women. Accordingly, we investigated the omega-3 intake and the concurrent stimulation of the DLPFC by tDCS and hypothesized that the synergy of these two treatments can increase the obtained effect size in patients with depression and overweight. Method: This research was a double-blind randomized controlled trial (RCT) with a factorial design consisting of four treatment and control groups. The participants were females with depression and overweight on an outpatient basis. They received 5 ml/day omega-3 syrup (545 mg DHA, 620 mg EPA) or placebo adjunct with 12 sessions sham/tDCS stimulation administered for 3 weeks with anode-left/cathode-right protocol in the prefrontal cortex (1.5 mA, 15 minutes’ stimulation / 15-20 minutes’ rest intervals/one visit per week, 4 stimulations per visit). Results: tDCS or omega-3 alone did not significantly improve the executive functions, depression, food cravings, and weight in the experimental groups compared to the control group (P > 0.05). However, tDCS adjunct with the omega-3 had a significant and positive effect on improving weight change (P = 0.011; df = 1; F = 1.27; Eta = 0.108) with a power of 0.73 compared to the control group. Furthermore, their interaction led to an improving trend in executive functions and a decreasing trend in food cravings which are clinically important. Conclusion: tDCS could strengthen the omega-3 mechanisms of effect through stimulating its accumulation site in the brain (i.e., the DLPFC) and the synergistic effects of these two treatments result in weight control as well as an improvement trend in the executive functions and food craving in women.
- 11 March 2024
- Published by Knowledge E DMCC in Iranian Journal of Psychiatry
- Vol. 19 (2) , 158-173
Open AccessThe Effectiveness of Transcranial Direct Current Stimulation (tDCS) and Omega-3 on Food Craving, Executive Functions, Weight, and Depressive Symptoms in Patients with Depression and Overweight: A Randomized Controlled Trial
Objective: The most important hypothesis of this research was based on the fact that the mechanism of the effect of omega-3 on depression and obesity is formed through its accumulation in the dorsolateral prefrontal cortex (DLPFC), especially in women. Accordingly, we investigated the omega-3 intake and the concurrent stimulation of the DLPFC by tDCS and hypothesized that the synergy of these two treatments can increase the obtained effect size in patients with depression and overweight. Method: This research was a double-blind randomized controlled trial (RCT) with a factorial design consisting of four treatment and control groups. The participants were females with depression and overweight on an outpatient basis. They received 5 ml/day omega-3 syrup (545 mg DHA, 620 mg EPA) or placebo adjunct with 12 sessions sham/tDCS stimulation administered for 3 weeks with anode-left/cathode-right protocol in the prefrontal cortex (1.5 mA, 15 minutes’ stimulation / 15-20 minutes’ rest intervals/one visit per week, 4 stimulations per visit). Results: tDCS or omega-3 alone did not significantly improve the executive functions, depression, food cravings, and weight in the experimental groups compared to the control group (P > 0.05). However, tDCS adjunct with the omega-3 had a significant and positive effect on improving weight change (P = 0.011; df = 1; F = 1.27; Eta = 0.108) with a power of 0.73 compared to the control group. Furthermore, their interaction led to an improving trend in executive functions and a decreasing trend in food cravings which are clinically important. Conclusion: tDCS could strengthen the omega-3 mechanisms of effect through stimulating its accumulation site in the brain (i.e., the DLPFC) and the synergistic effects of these two treatments result in weight control as well as an improvement trend in the executive functions and food craving in women.
- Open Access
- 11 March 2024
- Published by Knowledge E DMCC in Iranian Journal of Psychiatry
- Vol. 19 (2) , 155-157
Inflammatory Markers: Promising Tools for Diagnosis of Eating Disorders and Response to Treatment
The Article Abstract is not available.
- 11 March 2024
- Published by Knowledge E DMCC in Iranian Journal of Psychiatry
- Vol. 19 (2) , 155-157
Open AccessInflammatory Markers: Promising Tools for Diagnosis of Eating Disorders and Response to Treatment
The Article Abstract is not available.
- 5 May 2023
- Published by Springer Nature in Current Psychology
- Vol. 43 (6) , 5078-5089
Prevalence, sociodemographic correlates, and comorbidity of personality disorders in the general population of Iran
- 5 May 2023
- Published by Springer Nature in Current Psychology
- Vol. 43 (6) , 5078-5089
Prevalence, sociodemographic correlates, and comorbidity of personality disorders in the general population of Iran
- 14 August 2022
- Published by Springer Nature in Child Psychiatry & Human Development
- Vol. 55 (2) , 361-371
The Relationship of Parental Personality Disorders with Offspring Eating Disorders at Childhood and Adolescence Age
This study aimed to investigate parents’ PDs that could be associated with children and adolescents’ EDs. We studied association of parental PDs with offspring EDs in age group 6–18 years in a nationally representative sample of Iranians with 27,111 children and adolescents and their parents. We used a multistage random cluster sampling method. We used Millon Clinical Multiaxial Inventory-Third Edition and Persian present and lifetime version of Kiddie Schedule for Affective Disorders and Schizophrenia to measure parental PDs and children and adolescents’ EDs, respectively. We used descriptive statistics and binary logistic regression analysis methods to analyze the data. Maternal but not paternal PDs were significantly associated with EDs in offspring. Maternal antisocial, borderline, schizoid, histrionic, and compulsive PDs were significantly associated with EDs in offspring by 32.06, 4.66, 4.32, 3.15, and 1.71 odd ratios, respectively. Of EDs in offspring, anorexia nervosa and binge ED were significantly associated with maternal PDs.
- 14 August 2022
- Published by Springer Nature in Child Psychiatry & Human Development
- Vol. 55 (2) , 361-371
The Relationship of Parental Personality Disorders with Offspring Eating Disorders at Childhood and Adolescence Age
This study aimed to investigate parents’ PDs that could be associated with children and adolescents’ EDs. We studied association of parental PDs with offspring EDs in age group 6–18 years in a nationally representative sample of Iranians with 27,111 children and adolescents and their parents. We used a multistage random cluster sampling method. We used Millon Clinical Multiaxial Inventory-Third Edition and Persian present and lifetime version of Kiddie Schedule for Affective Disorders and Schizophrenia to measure parental PDs and children and adolescents’ EDs, respectively. We used descriptive statistics and binary logistic regression analysis methods to analyze the data. Maternal but not paternal PDs were significantly associated with EDs in offspring. Maternal antisocial, borderline, schizoid, histrionic, and compulsive PDs were significantly associated with EDs in offspring by 32.06, 4.66, 4.32, 3.15, and 1.71 odd ratios, respectively. Of EDs in offspring, anorexia nervosa and binge ED were significantly associated with maternal PDs.
- Open Access
- 30 June 2022
- Published by Maad Rayan Publishing Company in Journal of Multidisciplinary Care
- Vol. 11 (2) , 71-76
The study of the relationship between social capital and mental disorders in children and adolescents in Kohgiloyeh and Boyer Ahmad province, Iran
Background and aims: Social capital, by encouraging people to collaborate and engage in social interactions, has been considered as an effective factor for development of mental disorders. In the preset study, we aimed to investigate the relationship between different aspects of social capital and psychiatric disorders in children and adolescents. Methods: This study was conducted between 2016 and 2017 in Kohgiloyeh and Boyer-Ahmad province, Iran. A total of 1001 children and adolescents aged 6-18 years and their parents were randomly selected using multistage cluster sampling to participate in the study. The data in the present study were compiled using a Persian translated version of the Kiddie-SADS-Present and Lifetime Version (K-SADS-PL) semi-structured questionnaire as well as the Social Capital Questionnaire of Nahapiet and Ghoshal. The raw data were analyzed statistically using Fisher and chi-square tests. The statistical analysis was performed using SPSS 16.0 version. Results: Our results show that better relationship, cooperation, mutual understanding, and commitment are significantly and inversely correlated to psychiatric disorders among children and adolescents. In this regard we found that the mutual understanding (P=0.008) and relationships (P=0.001) are strongly related to social capital, while other components may have more or less effects. Conclusion: Our findings show that various aspects of social capital are associated with development of psychiatric disorders in children and adolescents. Some of the social capital components including better relationship, cooperation, mutual understanding, and obligation have significant effects; however, others including networks, values and trust could not exert significant effects on mental health.
- 30 June 2022
- Published by Maad Rayan Publishing Company in Journal of Multidisciplinary Care
- Vol. 11 (2) , 71-76
Open AccessThe study of the relationship between social capital and mental disorders in children and adolescents in Kohgiloyeh and Boyer Ahmad province, Iran
Background and aims: Social capital, by encouraging people to collaborate and engage in social interactions, has been considered as an effective factor for development of mental disorders. In the preset study, we aimed to investigate the relationship between different aspects of social capital and psychiatric disorders in children and adolescents. Methods: This study was conducted between 2016 and 2017 in Kohgiloyeh and Boyer-Ahmad province, Iran. A total of 1001 children and adolescents aged 6-18 years and their parents were randomly selected using multistage cluster sampling to participate in the study. The data in the present study were compiled using a Persian translated version of the Kiddie-SADS-Present and Lifetime Version (K-SADS-PL) semi-structured questionnaire as well as the Social Capital Questionnaire of Nahapiet and Ghoshal. The raw data were analyzed statistically using Fisher and chi-square tests. The statistical analysis was performed using SPSS 16.0 version. Results: Our results show that better relationship, cooperation, mutual understanding, and commitment are significantly and inversely correlated to psychiatric disorders among children and adolescents. In this regard we found that the mutual understanding (P=0.008) and relationships (P=0.001) are strongly related to social capital, while other components may have more or less effects. Conclusion: Our findings show that various aspects of social capital are associated with development of psychiatric disorders in children and adolescents. Some of the social capital components including better relationship, cooperation, mutual understanding, and obligation have significant effects; however, others including networks, values and trust could not exert significant effects on mental health.
- Open Access
- 30 June 2022
- Published by Korean Society of Sleep Medicine in Sleep Medicine Research
- Vol. 13 (1) , 22-30
Melatonin Effects in Women With Comorbidities of Overweight, Depression, and Sleep Disturbance: A Randomized Placebo Controlled Clinical Trial
Background and Objective Co-morbidity of obesity, sleep disturbance, and depression is common, especially among women. We aimed to evaluate the effects of melatonin on body weight, depression symptoms and sleep among women with co-morbidities of obesity, mild and moderate depression, and sleep disturbances seeking weight reduction compared with the placebo.Methods This double-blind, randomized clinical trial was performed on 43 patients with comorbidity of mild and moderate depression, overweight/obesity (body mass index ≥ 25) and sleep disturbance. After obtaining the informed consent forms they were randomly assigned to receive 3 mg melatonin or placebo at bed-time. We performed body composition assessments, Beck Depression Inventory, Spielberger State-Trait Anxiety Inventory and Pittsburgh Sleep Quality Index at the baseline, and 2, 4, 8, and 12 weeks after initiating of the study. We analyzed the data using analysis of variance repeated measures.Results Melatonin significantly reduced depression symptoms compared with the placebo, F = (1, 34) = 6.2, p = 0.017. Also, melatonin significantly improved sleep quality, F = (1, 33) = 8.0, p = 0.008. Besides, subjects on the melatonin reduced more weight compared with the placebo but difference between groups was not significant, F = (1, 41) = 0.2, p = 0.650. Patients in the melatonin group did not show significantly more side effects compared to placebo.Conclusions Based on our findings, melatonin was not able to significantly reduce the body weight more than placebo, but as a safe over-the-counter supplement, it may be helpful in patients with co-morbidities of sleep disturbance, mild and moderate depression, and obesity in reducing the symptoms of depression and insomnia.
- 30 June 2022
- Published by Korean Society of Sleep Medicine in Sleep Medicine Research
- Vol. 13 (1) , 22-30
Open AccessMelatonin Effects in Women With Comorbidities of Overweight, Depression, and Sleep Disturbance: A Randomized Placebo Controlled Clinical Trial
Background and Objective Co-morbidity of obesity, sleep disturbance, and depression is common, especially among women. We aimed to evaluate the effects of melatonin on body weight, depression symptoms and sleep among women with co-morbidities of obesity, mild and moderate depression, and sleep disturbances seeking weight reduction compared with the placebo.Methods This double-blind, randomized clinical trial was performed on 43 patients with comorbidity of mild and moderate depression, overweight/obesity (body mass index ≥ 25) and sleep disturbance. After obtaining the informed consent forms they were randomly assigned to receive 3 mg melatonin or placebo at bed-time. We performed body composition assessments, Beck Depression Inventory, Spielberger State-Trait Anxiety Inventory and Pittsburgh Sleep Quality Index at the baseline, and 2, 4, 8, and 12 weeks after initiating of the study. We analyzed the data using analysis of variance repeated measures.Results Melatonin significantly reduced depression symptoms compared with the placebo, F = (1, 34) = 6.2, p = 0.017. Also, melatonin significantly improved sleep quality, F = (1, 33) = 8.0, p = 0.008. Besides, subjects on the melatonin reduced more weight compared with the placebo but difference between groups was not significant, F = (1, 41) = 0.2, p = 0.650. Patients in the melatonin group did not show significantly more side effects compared to placebo.Conclusions Based on our findings, melatonin was not able to significantly reduce the body weight more than placebo, but as a safe over-the-counter supplement, it may be helpful in patients with co-morbidities of sleep disturbance, mild and moderate depression, and obesity in reducing the symptoms of depression and insomnia.
- Open Access
- 1 March 2022
- Published by Medical University of Lublin in Current Problems of Psychiatry
- Vol. 23 (1) , 41-58
Prevalence of the most common psychological problems during coronavirus epidemics: A systematic review and meta-analysis
Introduction: There have been so far three noteworthy epidemics caused by coronaviruses: SARS, MERS, and COVID-19. We aimed to review prevalence of the most common psychological problems during these epidemics. Material and methods: We conducted systematic reviews and meta-analyses of studies. A comprehensive search was performed in electronic databases PubMed/MEDLINE, Web of Science, PsycINFO/ProQuest, SCOPUS, and Google Scholar. Two independent reviewers searched for all English-language articles on psychological problems during coronavirus epidemics published by February 2021. We used DerSimonion-Laird random-effects model to estimate the prevalence of psychological problems. We conducted subgroup analyses to analyze the source of heterogeneity. Meta-regression model was also used. Results: Eighty-eight eligible papers were included. The prevalence of the most common psychological problems was insomnia (27%), depression (24.8%), stress (22%), and anxiety (12.4%), respectively. Subgroup analysis indicated that healthcare workers were more likely to have the mentioned psychological problems compared to survivors and the general population. According to meta-regression analyses, study tools and study populations were identified as the most important sources of heterogeneity. Variability in study tools and study populations was attributed to a high level of heterogeneity. Conclusions: This study suggested that people during coronavirus epidemics were exposed to insomnia, depression, stress, and anxiety far more than other psychological problems.
- 1 March 2022
- Published by Medical University of Lublin in Current Problems of Psychiatry
- Vol. 23 (1) , 41-58
Open AccessPrevalence of the most common psychological problems during coronavirus epidemics: A systematic review and meta-analysis
Introduction: There have been so far three noteworthy epidemics caused by coronaviruses: SARS, MERS, and COVID-19. We aimed to review prevalence of the most common psychological problems during these epidemics. Material and methods: We conducted systematic reviews and meta-analyses of studies. A comprehensive search was performed in electronic databases PubMed/MEDLINE, Web of Science, PsycINFO/ProQuest, SCOPUS, and Google Scholar. Two independent reviewers searched for all English-language articles on psychological problems during coronavirus epidemics published by February 2021. We used DerSimonion-Laird random-effects model to estimate the prevalence of psychological problems. We conducted subgroup analyses to analyze the source of heterogeneity. Meta-regression model was also used. Results: Eighty-eight eligible papers were included. The prevalence of the most common psychological problems was insomnia (27%), depression (24.8%), stress (22%), and anxiety (12.4%), respectively. Subgroup analysis indicated that healthcare workers were more likely to have the mentioned psychological problems compared to survivors and the general population. According to meta-regression analyses, study tools and study populations were identified as the most important sources of heterogeneity. Variability in study tools and study populations was attributed to a high level of heterogeneity. Conclusions: This study suggested that people during coronavirus epidemics were exposed to insomnia, depression, stress, and anxiety far more than other psychological problems.
- Open Access
- 17 October 2021
- Published by Wiley in Brain and Behavior
- Vol. 11 (11) , e2394
The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double‐blind, randomized, placebo‐controlled, clinical trial
Objective: Vitamin B6 has been linked to a variety of probable roles, including anti‐inflammatory, homocysteine‐lowering, serotonin‐regulating, and dopamine‐lowering. In this study, we investigated the possible effect of vitamin B6 on bipolar disorder in manic episode with psychotic feature in a placebo‐controlled double‐blind clinical trial in a psychiatric hospital.Methods: This study was performed on 50 patients who were equally divided into two groups (each group included 25 patients) using 80 mg of vitamin B6 daily or placebo. At the beginning and end of the study, they were evaluated for lab tests, inflammatory biomarkers and level of blood homocysteine. Also, at the baseline and in weeks 2, 4, and 8, they were evaluated based on the anthropometric measurements, score obtained from the Young Mania Questionnaire, Mini‐Mental State Examination (MMSE), and the Pittsburgh Sleep Questionnaire.Results: Accordingly, based on Yang Mania scoring scale, no significant difference was observed between the two groups receiving vitamin B6 and placebo (22.68 ± 5.39 vs. 21.80 ± 5.39 [p‐value = .51]). Based on MMSE, significant improvement in cognitive status was obtained in group placebo compared to vitamin B6 group (25.24 ± 1.96 vs. 24.40 ± 3.25, respectively [p‐value = .01]). At the Pittsburg scale (total, there was no statistically significant difference between the two groups receiving vitamin B6 and placebo (1.04 ± 0.20 vs. 0.48 ± 0.50 [p‐value = .23]). Additionally, no significant difference was observed between the two groups regarding the anthropometric status.Conclusions: According to this study, the daily dose of 80 mg of vitamin B6 for 8 weeks in patients with bipolar disorder in the manic episode with psychotic feature treated daily with lithium, was not associated with a significant improvement in mood status compared to the control–placebo group. It is recommended to perform similar studies in a multi‐center manner with a larger sample size and longer duration.
- 17 October 2021
- Published by Wiley in Brain and Behavior
- Vol. 11 (11) , e2394
Open AccessThe efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double‐blind, randomized, placebo‐controlled, clinical trial
Objective: Vitamin B6 has been linked to a variety of probable roles, including anti‐inflammatory, homocysteine‐lowering, serotonin‐regulating, and dopamine‐lowering. In this study, we investigated the possible effect of vitamin B6 on bipolar disorder in manic episode with psychotic feature in a placebo‐controlled double‐blind clinical trial in a psychiatric hospital.Methods: This study was performed on 50 patients who were equally divided into two groups (each group included 25 patients) using 80 mg of vitamin B6 daily or placebo. At the beginning and end of the study, they were evaluated for lab tests, inflammatory biomarkers and level of blood homocysteine. Also, at the baseline and in weeks 2, 4, and 8, they were evaluated based on the anthropometric measurements, score obtained from the Young Mania Questionnaire, Mini‐Mental State Examination (MMSE), and the Pittsburgh Sleep Questionnaire.Results: Accordingly, based on Yang Mania scoring scale, no significant difference was observed between the two groups receiving vitamin B6 and placebo (22.68 ± 5.39 vs. 21.80 ± 5.39 [p‐value = .51]). Based on MMSE, significant improvement in cognitive status was obtained in group placebo compared to vitamin B6 group (25.24 ± 1.96 vs. 24.40 ± 3.25, respectively [p‐value = .01]). At the Pittsburg scale (total, there was no statistically significant difference between the two groups receiving vitamin B6 and placebo (1.04 ± 0.20 vs. 0.48 ± 0.50 [p‐value = .23]). Additionally, no significant difference was observed between the two groups regarding the anthropometric status.Conclusions: According to this study, the daily dose of 80 mg of vitamin B6 for 8 weeks in patients with bipolar disorder in the manic episode with psychotic feature treated daily with lithium, was not associated with a significant improvement in mood status compared to the control–placebo group. It is recommended to perform similar studies in a multi‐center manner with a larger sample size and longer duration.